Samuel C. Blackman, Chief Medical Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 10,000 shares at $20.07 ($201K) on 2023-02-10, disclosed to the SEC on 2023-02-13.
Open-market sale of $201k DAWN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2024-11-12 | $751K | — | Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |